Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 30, 2026

Microvascular Decompression: Salient Surgical Principles and Technical Nuances
10:35

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Published on: July 5, 2011

[Microvascular decompression for cranial nerve hyperactive dysfunction].

Hao Yin1, Ting Lei, Chao You

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P.R. China. yinhao168@126.com

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery
|October 1, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-129-3p Targeting of MCU Protects Against Glucose Fluctuation-Mediated Neuronal Damage via a Mitochondrial-Dependent Intrinsic Apoptotic Pathway.

Diabetes, metabolic syndrome and obesity : targets and therapy·2021
Same author

Malignancy Risk Stratification Prediction of Amorphous Calcifications Based on Clinical and Mammographic Features.

Cancer management and research·2021
Same author

Comparison of clinical and histopathological characteristics of short-term progressive and non-progressive blood blister-like aneurysms.

Acta neurochirurgica·2021
Same author

Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis.

Neurosurgical review·2021
Same author

Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2020
Same author

Mass Detection and Segmentation in Digital Breast Tomosynthesis Using 3D-Mask Region-Based Convolutional Neural Network: A Comparative Analysis.

Frontiers in molecular biosciences·2020

Microvascular decompression (MVD) effectively treats cranial nerve hyperactive dysfunction caused by vascular compression. This procedure offers high success rates for trigeminal neuralgia and hemifacial spasm, with careful evaluation and technique crucial for optimal outcomes.

Area of Science:

  • Neurosurgery
  • Neurology
  • Vascular Surgery

Context:

  • Cranial nerve hyperactive dysfunction, including trigeminal neuralgia, hemifacial spasm, and spasmodic torticollis, significantly impacts patient quality of life.
  • Vascular compression of cranial nerves is a primary etiology for these conditions, necessitating targeted interventions.
  • Microvascular decompression (MVD) has emerged as a key surgical approach for alleviating these debilitating symptoms.

Purpose:

  • To evaluate the efficacy and outcomes of microvascular decompression (MVD) in a cohort of patients diagnosed with cranial nerve hyperactive dysfunction.
  • To identify the specific offending vessels implicated in different types of cranial nerve dysfunction.
  • To assess the complication rates and long-term results following MVD surgery.

Summary:

More Related Videos

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Related Experiment Videos

Last Updated: Jun 30, 2026

Microvascular Decompression: Salient Surgical Principles and Technical Nuances
10:35

Microvascular Decompression: Salient Surgical Principles and Technical Nuances

Published on: July 5, 2011

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

  • A study of 106 patients with cranial nerve hyperactive dysfunction treated with MVD revealed a total response rate of 90.6% over a 6-42 month follow-up period.
  • The curative rates for trigeminal neuralgia and hemifacial spasm were 83.9% and 81.8%, respectively, while spasmodic torticollis showed a 41.2% curative rate.
  • Commonly identified offending vessels included the superior cerebellar artery for trigeminal neuralgia and the anterior inferior cerebellar artery for hemifacial spasm.

Impact:

  • Microvascular decompression demonstrates significant therapeutic benefits for cranial nerve dysfunction attributed to vascular compression.
  • The findings underscore the importance of comprehensive preoperative assessment, surgical expertise, and intraoperative monitoring to maximize MVD efficacy and minimize complications.
  • This study contributes valuable data on MVD outcomes, guiding clinical practice and patient selection for neurosurgical interventions.